Registration Opens

Coffee and Case Vignettes
Neal Dixit, MD and Rola Khedraki, MD

PRODUCT THEATRE I - Lunch Session - Non-CME
Rethinking Hypertension Management: A Novel, Aldosterone-Targeted Approach for Uncontrolled Blood Pressure
Speakers: Vicky Kuo, PharmD, BCTXP and Vladamir Yurukov, PharmD
Supported by: AstraZeneca

Visit Exhibits

Welcome and Introduction to the 32nd Annual San Diego Summer Heart Failure Symposium
Barry Greenberg, MD and Marcus Anthony (Tony) Urey, MD

Fundamentals of Right Heart Catheterization
Hao Tran, MD

Recognizing Cardiogenic Shock and The Role of the Shock Team
Neal Dixit, MD

Left Ventricular Unloading in Cardiogenic Shock Due to Acute Myocardial Infarction
Diana Otero, MD

ECPR in San Diego – The UCSD Experience
Mazen Odish, MD

Management of Cardiogenic Shock: Picking the Right Device for the Right Patient
Rola Khedraki, MD

What’s New in Heart Transplant?
Hilary Shapiro, MD

Change in Paradigm: LVAD Prior to Transplant for Net Prolongation of Life
Marcus Anthony (Tony) Urey, MD

Patient Interview: Surviving Cardiogenic Shock
Dr. Urey and Patient

Panel Discussion
Dr. Marcus Anthony (Tony) Urey (Moderator)
Drs. Tran, Dixit, Otero, Odish, Khedraki, Shapiro, and Patient (Panelists)

Adjourn Day 1

Registration/Coffee/Visit Exhibits

Coffee and Case Vignettes
Pam Taub, MD and Barry Greenberg, MD

PRODUCT THEATRE II - Breakfast Session - Non-CME
Evaluating Attruby for Patients with ATTR-CM: An Overview and Patient Perspective
Speaker: Dr. Richard Wright
Sponsored by: BridgeBio

Visit Exhibits

Welcome and Introduction to Day 2 of the 32nd Annual San Diego Summer Heart Failure Symposium
Barry Greenberg, MD and Marcus Anthony (Tony) Urey, MD

Defining the Cardiorenal Metabolic Syndrome (CRMS)
Pam Taub, MD

FOUNDERS LECTURE
Dissecting the Role of Obesity in the Cardiometabolic Renal Syndrome
Tracey McLaughlin, MD

Role of GLP-1 Agonists in Patients with CRMS
Yehuda Handelsman, MD

GLP-1 Agonists for the Treatment of Obstructive Sleep Apnea and Obesity
Omar Mesarwi, MD

SGLT2 Inhibitors
Jia Shen, MD

Case Presentation and Panel Discussion
Jia Shen, MD (Moderator)
Drs. Taub, McLaughlin, Handelsman, Mesarwi, and Andrew Willeford, Pharm D (Discussants)

Break/Visit Exhibits

PRODUCT THEATRE III - Lunch Session - Non-CME
Introduction to AMVUTTRA® (vutrisiran)
Speaker: Rola Khedraki, MD
Supported by: Alnylam

Break/Visit Exhibits

Adult Congenital Heart Disease as a Cause of Heart Failure
Laith Alshawabkeh, MD

Evolving Strategies for Managing Individuals with Dyslipidemia
Harpreet Bhatia, MD

Recognizing and Treating Pulmonary Hypertension (PH) and Pulmonary Arterial Hypertension (PAH)
Demos Papamatheakis, MD

Pathways Through Which Aldosterone and the Mineralocorticoid Receptor Contribute to Cardiac and Renal Disease
Nick Wettersten, MD

Modulation of Aldosterone Effects Using MRAs: Results of Clinical Trials
Neal Dixit, MD

Beneficial Effects of Finerenone for Treating CRMS and HFpEF
Barry Greenberg, MD

Addressing Q and A from the Audience
Drs. Greenberg, Wettersten and Dixit (Discussants)

Recognizing Sarcoidosis and Other Infiltrative Cardiomyopathies
Quan Bui, MD

Biomarkers in Patients with Pre-Symptomatic and Symptomatic Heart Failure
Lori Daniels, MD

Break/Visit Exhibits

Management of Patients with Atrial Fibrillation
Jonathan Hsu, MD

FEATURED LECTURE
The 3 Pillars of Guideline Directed Medical Therapy for Heart Failure with Preserved Ejection Fraction (HFpEF)
Clyde Yancy, MD

Patient Advocate Presentation
Dr. Urey and Patient Advocate

Panel Discussion
Dr. Quan Bui (Moderator) – Drs, Yancy, Hsu and Trina Huynh, PharmD and Patient Advocate (Discussants)

ATTR-CM: Epidemiology, Clinical Clues, and Diagnosis
Ron Witteles, MD

ATTR-CM Management: Focus on Disease-Modifying Therapies, HF Therapies, and Future Directions
Ahmad Masri, MD, MS

Case Presentation: Optimization of ATTR-CM Management with Patient-Centered Care
Dr. Marcus Anthony (Tony) Urey (Moderator)
Drs. Witteles and Masri (Discussants)

Q/A with Audience
Drs. Urey, Witteles and Masri

Adjourn Day 2

Meet the Faculty and Other Attendees
Hors d’oeuvres/Cocktail Reception

Registration Opens

Coffee and Case Vignettes
Drs. Ben Cruz and Kimberly Hong

PRODUCT THEATRE IV - Breakfast Session - Non-CME
Evidence-Based Treatment of Recurrent Pericarditis
Speaker: John Ryan, MD
Sponsored by: Kiniksa

Visit Exhibits

Welcome and Introduction to the 32nd Annual San Diego Summer Heart Failure Symposium - Day 3
Barry Greenberg, MD and Marcus Anthony (Tony) Urey, MD

Rare Diseases, Genetic Cardiomyopathies and Gene Therapy
Barry Greenberg, MD

Testing for Genetic Cardiomyopathies: Rationale and Practice
Quan Bui, MD

FEATURED LECTURE
Gene Therapy – Progress, Challenges and Future Directions
Eric Adler, MD

Ongoing Studies of Gene Therapy for Patients with Monogenic Cardiomyopathy and Heart Failure
Kim Hong, MD

Patient Perspective on Gene Therapy for Chronic Disease
Patient Advocate

Panel Discussion
Dr. Greenberg (Moderator)
Drs. Bui, Adler and Hong (Discussants)

Break/Visit Exhibits

Introduction and Overview of the Session
Richard Wright, MD

Case Presentation
Hilary Shapiro, MD

Hypertrophic Cardiomyopathy (HCM) – Prevalence, Clinical Characteristics, Genetics, Imaging and Differential Diagnoses
Ahmad Masri, MD

Overview of Traditional Medical, Surgical and Device Therapies
Quan Bui, MD

Myosin Inhibitors – A New Approach for Treating HCM – Rationale, Pharmacology, Trial Results and Clinical Experience
Jorge Enciso Silva, MD

Hypertrophic Cardiomyopathy: A Patient’s Perspective
Lisa Salberg, Founder Hypertrophic Cardiomyopathy Foundation - Patient Advocate

Panel Discussion and Audience Questions
Richard Wright, MD (Moderator) – Drs. Shapiro, Bui, Silva, Masri, Lisa Salberg and Theresa Brush, PharmD (Panelists)

Concluding Remarks
Richard Wright, MD

PRODUCT THEATRE V - Lunch Session - Non-CME
CARDIO-TTRANSFORM - Baseline Characteristics
Speaker: Andrew Darlington, MD
Supported by: AstraZeneca

Break/Visit Exhibits

Annual Stanley H. Lloyd Lecture
Using CT, CT Angio and Other Imaging Modalities to Diagnosis Causes of Heart Failure
Matthew Budoff, MD

Guideline Directed Medical Therapies: The 4 Pillars of Management
Gregg Fonarow, MD

Additional Therapies for Treating Patients with HFrEF
Uri Elkayam, MD

Balancing GDMT and Hyperkalemia
Barry Greenberg, MD

Devices to Help Detect Congestion and Other Characteristics of Worsening Heart Failure
J. Thomas Heywood, MD

Novel Strategies and New Therapeutic Options for Decongesting Patients
Nick Wettersten, MD

Preventing Sudden Cardiac Death: How to Best Identify Patients at Risk and Treat Arrhythmias
Gordon Ho, MD

Living with Heart Failure: A Patient’s Perspective
Rhonda Monroe - Patient Advocate

Panel Discussion
Dr. Greenberg (Moderator)
Drs. Solomon, Fonarow, Elkayam, Wettersten and Ho, and Rhonda Monroe and Julia Mccain, PA (Panelists)

Adjourn Until the 33rd Annual Symposium, Summer 2027